On Air Now

Upcoming Shows

Program Schedule »

Listen

Listen Live Now » 1360 AM Northeast, WI 97.5 FM Green Bay, WI

Weather

Current Conditions(Green Bay,WI 54303)

More Weather »
30° Feels Like: 30°
Wind: ESE 3 mph Past 24 hrs - Precip: 0”
Current Radar for Zip

Today

Partly Cloudy 52°

Tonight

Showers Late 37°

Tomorrow

Rain 44°

Alerts

Alibaba, Yunfeng to invest $170 million in drug data project

A security guard walks past a logo of Alibaba (China) Technology Co. Ltd at its headquarters on the outskirts of Hangzhou, Zhejiang province
A security guard walks past a logo of Alibaba (China) Technology Co. Ltd at its headquarters on the outskirts of Hangzhou, Zhejiang province

BEIJING (Reuters) - Chinese e-commerce company Alibaba Group said on Thursday it would help fund a pharmaceutical information platform being developed by CITIC 21CN Co., a subsidiary of CITIC Group.

Alibaba Group and Yunfeng, a private equity firm founded by Alibaba Chairman Ma Yun, will subscribe for US$170 million of new shares in CITIC 21CN and take a 54.3 percent stake in the company.

The goal is to channel CITIC 21CN's vast pool of pharmaceutical product data into Alibaba's e-commerce, cloud computing and big data systems to win new business.

Alibaba's business-to-consumer platform, Tmall.com, already hosts e-stores from more than 80 drugstore chains.

The Chinese Academy of Social Sciences estimates that China's pharmaceutical market exceeded 1 trillion yuan in 2013 and may top 2.3 trillion yuan by 2020.

(Reporting by Chen Aizhu; editing by Tom Pfeiffer)

Comments